Global Insulin Pumps Device Pipeline Product Landscape Report 2021: Products Under Development, Companies and Product Overview, Recent Developments - ResearchAndMarkets.com

The "Insulin Pumps - Medical Devices Pipeline Product Landscape, 2021" report has been added to ResearchAndMarkets.com's offering.

This report provides comprehensive information about the Insulin Pumps pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

An insulin pump is an insulin delivery device that administers programmed doses of insulin for diabetes management. The device consists of a battery run pump, an insulin reservoir and an infusion set with a tubing system for subcutaneous intervention.

Scope

• Extensive coverage of the Insulin Pumps under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Insulin Pumps and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment/industry

Reasons to Buy

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Insulin Pumps under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Key Topics Covered:

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Insulin Pumps Overview

3 Products under Development

3.1 Insulin Pumps - Pipeline Products by Stage of Development

3.2 Insulin Pumps - Pipeline Products by Segment

3.3 Insulin Pumps - Pipeline Products by Territory

3.4 Insulin Pumps - Pipeline Products by Regulatory Path

3.5 Insulin Pumps - Pipeline Products by Estimated Approval Date

4 Insulin Pumps - Pipeline Products under Development by Companies

4.1 Insulin Pumps Companies - Pipeline Products by Stage of Development

4.2 Insulin Pumps - Pipeline Products by Stage of Development

5 Insulin Pumps Companies and Product Overview

5.1 Amrita Vishwa Vidyapeetham Company Overview

5.2 Andain, Inc Company Overview

5.3 Becton Dickinson and Co Company Overview

5.4 Cellnovo Ltd Company Overview

5.5 Debiotech SA Company Overview

5.6 Hospira Inc Company Overview

5.7 Insulet Corp Company Overview

5.8 LifeScan Inc Company Overview

5.9 MedSolve Technologies, Inc. Company Overview

5.10 Medtronic Plc Company Overview

5.11 MicroPort Scientific Corp Company Overview

5.12 Modular Medical Inc Company Overview

5.13 Pennsylvania State University Company Overview

5.14 Phluid Corporation Company Overview

5.15 PhysioLogic Devices Inc Company Overview

5.16 Qlibrium Inc Company Overview

5.17 SFC Fluidics LLC Company Overview

5.18 Sooil Development Co., Ltd. Company Overview

5.19 Spring Health Solutions Ltd. Company Overview

5.20 Tandem Diabetes Care Inc Company Overview

5.21 Thermalin Inc Company Overview

5.22 Triple Jump Israel Ltd Company Overview

5.23 Univlabs Technologies Pvt Ltd Company Overview

5.24 ViCentra BV Company Overview

5.25 Ypsomed Holding AG Company Overview

6 Insulin Pumps- Recent Developments

6.1 May 06, 2021: Insulet Reports First Quarter 2021 Revenue Increase of 27% Year-Over-Year

6.2 May 05, 2021: Lilly to Participate in Bank of America Securities 2021 Health Care Conference

6.3 Apr 29, 2021: Integer Holdings Reports First Quarter 2021 Results

6.4 Apr 21, 2021: F. Hoffman La Roche's sales performance for the first quarter of 2021

6.5 Apr 05, 2021: Insulet to Announce First Quarter 2021 Financial Results on May 6, 2021

6.6 Apr 01, 2021: Integer Schedules First Quarter 2021 Earnings Release and Conference Call for April 29, 2021

6.7 Mar 16, 2021: Modular Medical relocates to larger corporate headquarters

6.8 Feb 18, 2021: Integer Holdings Reports Results for Fourth Quarter and Full Year 2020

6.9 Feb 16, 2021: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2021

6.10 Feb 16, 2021: Tandem Diabetes Care Announces Upcoming Virtual Conference Presentations

6.11 Feb 01, 2021: Integer Appoints Sheila Antrum, Cheryl Capps and Tyrone Jeffers to Board of Directors

6.12 Jan 15, 2021: Integer Schedules Fourth Quarter and Full-Year 2020 Earnings Release and Conference Call for February 18, 2021

6.13 Jan 06, 2021: Abbott Hosts Conference Call for Fourth-Quarter Earnings

6.14 Jan 04, 2021: Ypsomed reaches agreement in legal dispute with Insulet

7 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/daynu0

View source version on businesswire.com: https://www.businesswire.com/news/home/20211125006108/en/